⌘K

Login Start Free

Home/Filings/4/0001855763-21-000020

4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001855763-21-000020

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 1:40 PM ET

Size

8.3 KB

Accession

0001855763-21-000020

Insider Transaction Report

Form 4

Period: 2021-06-08

Lexaria Bioscience Corp.LEXX

DOCHERTY JOHN MARTIN

DirectorPresident

Transactions

Award
Stock Options
2021-06-08+18,334→ 49,668 total
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (18,334 underlying)

Holdings

Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (13,334 underlying)
13,334
common shares
(indirect: Private Holding Company)
54,075
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying)
31,334

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001638727

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 1:40 PM ET
Size: 8.3 KB

View on SEC.gov